General Dynamics Armament and Technical Products has won a US$43m contract modification to produce and test Joint Biological Point Detection Systems (JBPDS).
The award by the US Army Research Development and Engineering Command Acquisition Centre is a modification of a 2004 contract, and brings the total value of that contract to US$200m.
Go deeper with GlobalData
JBPDS is a self-contained instrument suite that rapidly detects and identifies biological warfare agents.
General Dynamics says it is available in man-potable, shelter-based, ship-based and trailer-mounted variants.
By staff writer
